Eye tracking to help detect autism in children born preterm
Tests an eye-tracking device alongside usual autism assessment in children born early.
Plain-language title generated from the registry record
Registry title: Eye Tracking and Autism in Former Preterm Infants
Key facts
- Where
- Indianapolis, United StatesSee the site
Where in United States
- Riley Hospital for ChildrenIndianapolis, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Indiana University
- Trial code
- NCT07764822
- Record updated
- 14 August 2026
- Original description
This is a single center, intervention study of integrating the eye-tracking (ET) biomarker battery into the existing autism evaluation process at the Riley Early Years Program (EYP). Eligible participants referred for autism testing through EYP will undergo a traditional comprehensive diagnostic assessment by an EYP clinical psychologist.Read full original descriptionShow less
Eye-Tracking Biomarkers for Early Autism Detection in Former Preterm Infants
This is a single center, intervention study of integrating the eye-tracking (ET) biomarker battery into the existing autism evaluation process at the Riley Early Years Program (EYP). Eligible participants referred for autism testing through EYP will undergo a traditional comprehensive diagnostic assessment by an EYP clinical psychologist.
Inclusion: Children born at <37 weeks' gestational age who are 14-48 months old at time of referral; Ambulatory (i.e., cruising, walking); Without significant visual impairment; Referred for autism testing through EYP (i.e. medium- or high-risk M-CHAT-R/F screening result at 16-22 months corrected age or by referral to Early Years based on caregiver or provider concern for autism).
Exclusion: Non-English-speaking participants and families.